Full Text View
Tabular View
No Study Results Posted
Related Studies
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
This study has been completed.
Study NCT00019604   Information provided by National Institutes of Health Clinical Center (CC)

First Received on July 11, 2001.   Last Updated on May 11, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Liver Cancer
Metastatic Cancer
Additional conditions recognized in this trial
Liver Neoplasms
Neoplasm Metastasis
Neoplasms
Neoplasms, Second Primary
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Liver Diseases
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Interventions listed in this trial
computed tomography
magnetic resonance imaging
positron emission tomography
radiofrequency ablation
radionuclide imaging
ultrasound imaging
fludeoxyglucose F 18
gadopentetate dimeglumine
Sponsors listed in this trial
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services